AdaptHealth Corp. (AHCO) vs Monte Rosa Therapeutics, Inc. (GLUE)
A side-by-side comparison of AdaptHealth Corp. and Monte Rosa Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AHCO
AdaptHealth Corp.
$5.85HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
GLUE
Monte Rosa Therapeutics, Inc.
$9.96HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — AHCO vs GLUE
growth of $100 · dividends reinvested · last 5yAHCO -80.4% (-27.8%/yr)GLUE -51.5% (-13.5%/yr)GLUE compounded faster over this window
AHCO GLUE
AHCO vs GLUE: by the numbers
- •GLUE is the larger company ($841M vs $796M market cap).
- •Both run net losses; AHCO's is the smaller (-7.58% vs -560.85% net margin).
Metrics side by side
Valuation
| Metric | AHCO | GLUE |
|---|---|---|
| P/S ratio | 0.26 | 29.29 |
| P/B ratio | 0.58 | 1.73 |
| EV / EBITDA | 6.66 | N/A |
| FCF yield | 12.27% | N/A |
Profitability
| Metric | AHCO | GLUE |
|---|---|---|
| Gross margin | 10.37% | 92.94% |
| Operating margin | -0.31% | -43.83% |
| Net margin | -7.58% | -560.85% |
| ROE | -16.56% | -33.06% |
| ROIC | -0.26% | -28.69% |
Growth (annualized)
| Metric | AHCO | GLUE |
|---|---|---|
| Revenue CAGR (5Y) | 11.68% | N/A |
| FCF CAGR (5Y) | 7.07% | N/A |
| Total return CAGR (5Y) | -24.65% | -12.32% |
Frequently asked
- How have AHCO and GLUE total returns compared?
- Over the past 5 years, AHCO delivered -24.65% and GLUE delivered -12.32% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AdaptHealth ROEMonte Rosa Therapeutics ROEAdaptHealth operating marginMonte Rosa Therapeutics operating marginAdaptHealth revenue growthMonte Rosa Therapeutics revenue growthAdaptHealth free cash flowMonte Rosa Therapeutics free cash flow
AdaptHealth & Monte Rosa Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.